Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-04-29

FDA Approved: EXCEDRIN MIGRAINE GELTABS — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

FDA approved a supplemental application for Excedrin Migraine Geltabs, a combination of acetaminophen, aspirin, and caffeine, from Haleon US Holdings LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Excedrin Migraine GelTabs (acetaminophen, aspirin, caffeine)

Snippet

SUPPL AP for EXCEDRIN MIGRAINE GELTABS (ACETAMINOPHEN, ASPRIN, CAFFEINE)